Dian J Cao1,2, Gabriele G Schiattarella3, Elisa Villalobos3, Nan Jiang3, Herman I May3, Tuo Li4, Zhijian J Chen4,5, Thomas G Gillette3, Joseph A Hill1,4. 1. Departments of Internal Medicine (Cardiology) (D.C., G.G.S., E.V., N.J., H.I.M., T.G.G., J.A.H.) dian.cao@utsouthwestern.edu joseph.hill@utsouthwestern.edu. 2. VA North Texas Health System (D.C.). 3. Departments of Internal Medicine (Cardiology) (D.C., G.G.S., E.V., N.J., H.I.M., T.G.G., J.A.H.). 4. Molecular Biology (T.L., Z.J.C., J.A.H.). 5. Howard Hughes Medical Institute (Z.J.C.), University of Texas Southwestern Medical Center, Dallas.
Abstract
BACKGROUND: Myocardium irreversibly injured by ischemic stress must be efficiently repaired to maintain tissue integrity and contractile performance. Macrophages play critical roles in this process. These cells transform across a spectrum of phenotypes to accomplish diverse functions ranging from mediating the initial inflammatory responses that clear damaged tissue to subsequent reparative functions that help rebuild replacement tissue. Although macrophage transformation is crucial to myocardial repair, events governing this transformation are poorly understood. METHODS: Here, we set out to determine whether innate immune responses triggered by cytoplasmic DNA play a role. RESULTS: We report that ischemic myocardial injury, along with the resulting release of nucleic acids, activates the recently described cyclic GMP-AMP synthase-stimulator of interferon genes pathway. Animals lacking cyclic GMP-AMP synthase display significantly improved early survival after myocardial infarction and diminished pathological remodeling, including ventricular rupture, enhanced angiogenesis, and preserved ventricular contractile function. Furthermore, cyclic GMP-AMP synthase loss of function abolishes the induction of key inflammatory programs such as inducible nitric oxide synthase and promotes the transformation of macrophages to a reparative phenotype, which results in enhanced repair and improved hemodynamic performance. CONCLUSIONS: These results reveal, for the first time, that the cytosolic DNA receptor cyclic GMP-AMP synthase functions during cardiac ischemia as a pattern recognition receptor in the sterile immune response. Furthermore, we report that this pathway governs macrophage transformation, thereby regulating postinjury cardiac repair. Because modulators of this pathway are currently in clinical use, our findings raise the prospect of new treatment options to combat ischemic heart disease and its progression to heart failure.
BACKGROUND: Myocardium irreversibly injured by ischemic stress must be efficiently repaired to maintain tissue integrity and contractile performance. Macrophages play critical roles in this process. These cells transform across a spectrum of phenotypes to accomplish diverse functions ranging from mediating the initial inflammatory responses that clear damaged tissue to subsequent reparative functions that help rebuild replacement tissue. Although macrophage transformation is crucial to myocardial repair, events governing this transformation are poorly understood. METHODS: Here, we set out to determine whether innate immune responses triggered by cytoplasmic DNA play a role. RESULTS: We report that ischemic myocardial injury, along with the resulting release of nucleic acids, activates the recently described cyclic GMP-AMP synthase-stimulator of interferon genes pathway. Animals lacking cyclic GMP-AMP synthase display significantly improved early survival after myocardial infarction and diminished pathological remodeling, including ventricular rupture, enhanced angiogenesis, and preserved ventricular contractile function. Furthermore, cyclic GMP-AMP synthase loss of function abolishes the induction of key inflammatory programs such as inducible nitric oxide synthase and promotes the transformation of macrophages to a reparative phenotype, which results in enhanced repair and improved hemodynamic performance. CONCLUSIONS: These results reveal, for the first time, that the cytosolic DNA receptor cyclic GMP-AMP synthase functions during cardiac ischemia as a pattern recognition receptor in the sterile immune response. Furthermore, we report that this pathway governs macrophage transformation, thereby regulating postinjury cardiac repair. Because modulators of this pathway are currently in clinical use, our findings raise the prospect of new treatment options to combat ischemic heart disease and its progression to heart failure.
Authors: Ruth Wassermann; Muhammet F Gulen; Claudia Sala; Sonia Garcia Perin; Ye Lou; Jan Rybniker; Jonathan L Schmid-Burgk; Tobias Schmidt; Veit Hornung; Stewart T Cole; Andrea Ablasser Journal: Cell Host Microbe Date: 2015-06-02 Impact factor: 21.023
Authors: William Chan; Stephen J Duffy; David A White; Xiao-Ming Gao; Xiao-Jun Du; Andris H Ellims; Anthony M Dart; Andrew J Taylor Journal: JACC Cardiovasc Imaging Date: 2012-09
Authors: Ingo Hilgendorf; Louisa M S Gerhardt; Timothy C Tan; Carla Winter; Tobias A W Holderried; Benjamin G Chousterman; Yoshiko Iwamoto; Ronglih Liao; Andreas Zirlik; Marielle Scherer-Crosbie; Catherine C Hedrick; Peter Libby; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski Journal: Circ Res Date: 2014-03-13 Impact factor: 17.367
Authors: Junya Takagawa; Yan Zhang; Maelene L Wong; Richard E Sievers; Neel K Kapasi; Yan Wang; Yerem Yeghiazarians; Randall J Lee; William Grossman; Matthew L Springer Journal: J Appl Physiol (1985) Date: 2007-03-08
Authors: Hamed Emami; Parmanand Singh; Megan MacNabb; Esad Vucic; Zachary Lavender; James H F Rudd; Zahi A Fayad; Joshua Lehrer-Graiwer; Magnus Korsgren; Amparo L Figueroa; Jill Fredrickson; Barry Rubin; Udo Hoffmann; Quynh A Truong; James K Min; Amos Baruch; Khurram Nasir; Matthias Nahrendorf; Ahmed Tawakol Journal: JACC Cardiovasc Imaging Date: 2015-01-07
Authors: Jiayuan Y Kou; Ying Li; Zhaoyu Y Zhong; Yueqing Q Jiang; Xuesong S Li; Xiaobo B Han; Zhongni N Liu; Ye Tian; Liming M Yang Journal: Cell Death Dis Date: 2017-01-19 Impact factor: 8.469
Authors: Massimo Bonora; Mariusz R Wieckowski; David A Sinclair; Guido Kroemer; Paolo Pinton; Lorenzo Galluzzi Journal: Nat Rev Cardiol Date: 2019-01 Impact factor: 32.419